Sign inGet started

Reed Joshua

Insider CIK 1746541 · ALDX Chief Financial Officer · ALKS SVP, Chief Financial Officer · SRRK Director · OMGA Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALKS Alkermes plc. M Exercise deriv2026-10-082026-10-099,164— —27,492SEC↗
ALKS Alkermes plc. F Tax w/h2026-10-082026-10-094,069$40.11 $163.2K5,095SEC↗
ALKS Alkermes plc. M Exercise2026-10-082026-10-099,164— —9,164SEC↗
SRRK Scholar Rock Holding Corp S Sale2026-07-012026-07-062,105$53.50 $112.6K20,466SEC↗
SRRK Scholar Rock Holding Corp S Sale2026-07-012026-07-06948$54.28 $51.5K19,518SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2026-06-042026-06-084,310— $04,310SEC↗
SRRK Scholar Rock Holding Corp A Award2026-06-042026-06-086,839— $022,571SEC↗
ALKS Alkermes plc. A Award deriv2026-03-022026-03-0430,854— $030,854SEC↗
ALKS Alkermes plc. A Award deriv2026-03-022026-03-0466,430— $066,430SEC↗
ALKS Alkermes plc. A Award deriv2025-10-082025-10-10158,743— $0158,743SEC↗
ALKS Alkermes plc. A Award deriv2025-10-082025-10-1036,656— $036,656SEC↗
SRRK Scholar Rock Holding Corp S Sale2025-05-292025-05-304,900$29.68 $145.4K16,232SEC↗
SRRK Scholar Rock Holding Corp S Sale2025-05-292025-05-30500$30.04 $15.0K15,732SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2025-05-222025-05-239,206— $09,206SEC↗
SRRK Scholar Rock Holding Corp A Award2025-05-222025-05-237,632— $021,132SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2024-06-272024-07-0118,000— $018,000SEC↗
SRRK Scholar Rock Holding Corp A Award2024-06-272024-07-0113,500— $013,500SEC↗
OMGA Omega Therapeutics, Inc. A Award deriv2024-02-072024-02-09110,000— $0110,000SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2023-06-212023-06-2236,000— $036,000SEC↗
OMGA Omega Therapeutics, Inc. A Award deriv2023-02-282023-03-0255,000— $055,000SEC↗
OMGA Omega Therapeutics, Inc. A Award deriv2022-10-272022-10-2855,000— $055,000SEC↗
OMGA Omega Therapeutics, Inc. A Award deriv2022-05-312022-06-02320,000— $0320,000SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2022-05-262022-05-2728,000— $028,000SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2022-03-302022-04-01250,000— $0250,000SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award2022-03-302022-04-0193,322— $0274,825SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2021-04-122021-04-14150,185— $0150,185SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2021-03-162021-03-1815,600— $015,600SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2020-03-022020-03-04137,707— $0137,707SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2020-03-022020-03-06250,000— $0250,000SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award2020-03-022020-03-04250,000— $0285,774SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award2020-03-022020-03-06137,707— $0173,481SEC↗
ALDX Aldeyra Therapeutics, Inc. P Buy2019-09-052019-09-093,200$4.71 $15.1K35,774SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2019-03-052019-03-07250,000— $0250,000SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award2019-03-052019-03-0729,637— $029,637SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2018-07-302018-08-0175,000— $075,000SEC↗